1262 — Labixiaoxin Snacks Income Statement
0.000.00%
- HK$273.02m
- HK$702.99m
- CNY866.68m
Annual income statement for Labixiaoxin Snacks, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 509 | 648 | 684 | 764 | 867 |
Cost of Revenue | |||||
Gross Profit | 167 | 224 | 244 | 219 | 235 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 453 | 601 | 725 | 846 | 940 |
Operating Profit | 55.5 | 47.5 | -40.3 | -82.1 | -73.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 16 | 17 | -67.7 | -105 | -93.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -29.4 | -65.2 | -75.3 | -105 | -93.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -29.4 | -65.2 | -75.3 | -105 | -93.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -29.4 | -65.2 | -75.3 | -105 | -93.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.605 | -0.56 | -0.47 | -0.657 | -0.507 |